Drug Approval | May 12, 2023
USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Metronidazole is an antibiotic used on the skin to treat a certain skin disorder known as rosacea
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
India's strategy against Covid was more effective than any other countries in the world
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
Subscribe To Our Newsletter & Stay Updated
